BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 962991)

  • 1. Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.
    Marti JH; Thomson DM
    Br J Cancer; 1976 Aug; 34(2):116-33. PubMed ID: 962991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti-tumour immunity. III. "Blockade" of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients.
    Grosser N; Thompson DM
    Int J Cancer; 1976 Jul; 18(1):58-66. PubMed ID: 59711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
    Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
    Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. II. Monocyte reacts with tumour antigen via cytophilic anti-tumour antibody.
    Marti JH; Grosser N; Thomson DM
    Int J Cancer; 1976 Jul; 18(1):48-57. PubMed ID: 947860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.
    Müller S; Ernst TM
    Arch Dermatol Res; 1980; 268(2):167-81. PubMed ID: 7425670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.
    O'Connor R; MacFarlane JK; Murray D; Thomson DM
    Br J Cancer; 1978 Dec; 38(6):674-84. PubMed ID: 369586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.
    Lopez M; O'Connor R; MacFarlane JK; Thomson DM
    Br J Cancer; 1978 Dec; 38(6):660-73. PubMed ID: 369585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
    Plain MJ; Whitehead RH; Jose DG
    Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma.
    Winter M; Nelson DS; Milton GW
    Aust N Z J Med; 1980 Aug; 10(4):405-9. PubMed ID: 7000060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of anti-tumour cell mediated immunity and serum blocking factors in cancer patients by the leucocyte adherence inhibition test.
    Halliday WJ; Maluish A; Isbister WH
    Br J Cancer; 1974 Jan; 29(1):31-5. PubMed ID: 4820944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
    Holán V; Síbl O; Hasek M
    Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further study of specific immunoreactivity in patients with malignant melanoma of uveal tissue by LAI assay.
    Kalafut F; Cernák A
    Neoplasma; 1982; 29(5):561-6. PubMed ID: 7177245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer.
    Onji M
    Gastroenterol Jpn; 1984 Aug; 19(4):328-35. PubMed ID: 6333369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS).
    Harding MW; Yang TJ
    Cancer Immunol Immunother; 1985; 19(3):168-76. PubMed ID: 3891077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between the macrophage migration inhibition test (MMI) and the leucocyte adherence inhibition test (LAI) in patients with melanoma and carcinoma of the colon.
    Isbister WH
    N Z Med J; 1978 Oct; 88(622):327-30. PubMed ID: 366475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tube leukocyte adherence inhibition assay for the detection of anti-tumor immunity. I. Monocyte is the reactive cell.
    Grosser N; Marti JH; Proctor JW; Thomson DM
    Int J Cancer; 1976 Jul; 18(1):39-47. PubMed ID: 1084863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of soluble melanoma cell membrane antigens in metastatic cells of various organs and further studies of antigens present in primary melanoma.
    Hollinshead AC
    Cancer; 1975 Oct; 36(4):1282-8. PubMed ID: 51680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of specific immunoreactivity by LAI assay in patients with malignant melanoma of uveal tissue.
    Kalafut F; Cernák A; Pham Manh Hung
    Neoplasma; 1979; 26(3):299-305. PubMed ID: 394010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.